Effect of the addition of rituximab to salvage chemotherapy prior to autologous stem cell transplant in aggressive CD20+ lymphoma: a cohort comparison from the NCIC Clinical Trials Group Study LY.12*

Tara Baetz, Bingshu E. Chen, Stephen Couban, C. Tom Kouroukis, Rena Buckstein, John Kuruvilla, Kang Howson-Jan, David Szwajcer, Massimo Federico, Ralph M. Meyer, Marina S. Djurfeldt, Annette E. Hay, Lois Shepherd, Michael Crump

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)
Original languageEnglish
Pages (from-to)64-69
Number of pages6
JournalLeukemia and Lymphoma
Volume58
Issue number1
DOIs
Publication statusPublished - Jan 2 2017
Externally publishedYes

ASJC Scopus Subject Areas

  • Hematology
  • Oncology
  • Cancer Research

Keywords

  • Autologous transplant
  • rituximab
  • salvage chemotherapy

Fingerprint

Dive into the research topics of 'Effect of the addition of rituximab to salvage chemotherapy prior to autologous stem cell transplant in aggressive CD20+ lymphoma: a cohort comparison from the NCIC Clinical Trials Group Study LY.12*'. Together they form a unique fingerprint.

Cite this